Science News
from research organizations

Screening for transformed human mesenchymal stromal cells with tumorigenic potential

Date:
January 29, 2014
Source:
Society for Experimental Biology and Medicine
Summary:
Spontaneous transformation of human mesenchymal stem/stromal cells has been observed during long-term expansion in cell culture, although it is rare. Engrafting these transformed cells into immunodeficient mice leads to the formation of solid tumors. Using high-throughput profiling methods, a panel of RNA molecules was identified as potential biomarkers for screening for these transformed cells in cell culture.
Share:
         
Total shares:  
FULL STORY

Researchers at Erasmus University Medical Center Rotterdam, The Netherlands, led by Dr. Qiuwei Pan and Dr. Luc van der Laan, have discovered that spontaneous tumorigenic transformation of human mesenchymal stem/stromal cells (MSCs) can occur during cell culture expansion, although the frequency is relatively low and often only observed after extensive passage in culture. This report appears in the January 2014 issue of Experimental Biology and Medicine.

Currently, MSCs are being widely investigated as a potential treatment for various diseases. According to ClinicalTrials.gov, over 350 clinical trials using MSCs have been registered by the end of 2013 (with a search of: mesenchymal stem cells). For cell transplantation, MSCs are often isolated from either the patient or from a third party donor, and then expanded in cell culture before therapeutic application. In fact, spontaneous transformation of primary cells in cell culture has been well-investigated over decades. Malignant transformation of murine and monkey MSCs has also recently been reported.

The current study confirmed that spontaneous tumorigenic transformation of human MSCs can occur during cell culture expansion. This potentially has large implications for the clinical application of ex vivo expanded MSCs. "Although this transformation is rare, we do need to carefully examine the presence of these aberrant cells in MSC cultures, before transplanting into patients," stresses the first author Dr. Pan. "We now have identified RNA molecule signatures that can be applied as a potential biomarker for the detection of these dangerous cells in long-term cultures," said senior author Dr. van der Laan. "However, further research is required to validate this biomarker in clinical grade cultures of MSCs that are used in clinical trials."

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said "This study provides a possible method for testing the safety of expanded adult stem cells. We look forward to the validation of these RNA biomarkers."


Story Source:

The above story is based on materials provided by Society for Experimental Biology and Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Q. Pan, S. M. Fouraschen, P. E. d. Ruiter, W. N. Dinjens, J. Kwekkeboom, H. W. Tilanus, L. J. v. d. Laan. Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells. Experimental Biology and Medicine, 2013; 239 (1): 105 DOI: 10.1177/1535370213506802

Cite This Page:

Society for Experimental Biology and Medicine. "Screening for transformed human mesenchymal stromal cells with tumorigenic potential." ScienceDaily. ScienceDaily, 29 January 2014. <www.sciencedaily.com/releases/2014/01/140129165425.htm>.
Society for Experimental Biology and Medicine. (2014, January 29). Screening for transformed human mesenchymal stromal cells with tumorigenic potential. ScienceDaily. Retrieved May 4, 2015 from www.sciencedaily.com/releases/2014/01/140129165425.htm
Society for Experimental Biology and Medicine. "Screening for transformed human mesenchymal stromal cells with tumorigenic potential." ScienceDaily. www.sciencedaily.com/releases/2014/01/140129165425.htm (accessed May 4, 2015).

Share This Page:


Recommended Content
 


Health & Medicine News
May 4, 2015

Latest Headlines
updated 12:56 pm ET